Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study
Abstract Renal cell carcinoma (RCC) affects 10%–20% of patients annually, often with metastases present. This study evaluated the impact of systemic therapy before nephrectomy in patients with unresectable or metastatic renal cell carcinoma (RCC). Patients receiving upfront immune checkpoint inhibit...
Saved in:
| Main Authors: | Sho Kiyota, Takashi Yoshida, Takahiro Nakamoto, Eri Jino, Takao Mishima, Hidefumi Kinoshita |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | BJUI Compass |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/bco2.419 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?
by: Narimantas E. Samalavicius, et al.
Published: (2016-12-01) -
Multiple roles of branched-chain amino acid metabolism in tumour progression
by: Lin Wang, et al.
Published: (2025-04-01) -
Prior Immune Checkpoint Inhibitor Treatment Is a Risk Factor for Treatment‐Related Adverse Events in Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab
by: Naohiro Watanabe, et al.
Published: (2025-04-01) -
Cardiac myxoma: a comprehensive review
by: Chigozie C. Okongwu, et al.
Published: (2025-03-01) -
Another power of antibody-drug conjugates: immunomodulatory effect and clinical applications
by: Ruotong Shi, et al.
Published: (2025-08-01)